← Back
Clorox
CLX · listed on the New York Stock Exchange · worth $10.81 billion
$88.67
+2.11% on Oct 29
One insider buy in the last year, $416.5K in all. None in the last two weeks. Two members of Congress reported trading Clorox in the last year.
Green dot = an insider bought◆ = company newsA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
120.5M shares
100% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, one insider bought Clorox stock and none sold.
How each buyer's earlier purchases went: the stock about six months later, beside the S&P 500 over the same days. Purchases planned in advance are left out. Past results, not a forecast.
Director
Pierre R. Breber
Bought $416.5K on Nov 21, 2025 — 4,000 shares at $104.13, held through a trust or family, 31% of what they now own.
0 of 1 earlier purchase did better than the S&P 500
US Congress
Members of Congress who reported trading Clorox in the last year. They have up to 45 days to report, so the newest trades show up late.
MemberTradeAmountWhose accountTradedReported
All reports
Every insider trade and SEC report we hold for Clorox.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Nov 24, 2025BoughtPierre R. BreberNov 24, 2025 · Traded Nov 21, 2025 · Director+31%via a trust or family4,000 @ $104.13$416.5K
Sep 8, 2025SoldEric H. ReynoldsSep 8, 2025 · Traded Sep 4, 2025 · EVP - Chief Operating Officer15,041 @ $123.78$1.86M
Analysts, earnings and news
Analysts' price target
$100.76 average
17 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
3 of 4 quarters above
Q2 '26$1.66 a share+$0.01
Q1 '26$1.64 a share+$0.10
Q4 '25$1.39 a share−$0.04
Q3 '25$0.85 a share+$0.07